ResearcherTaipei Medical UniversityNo recent work listed

Yuan‐Chin Tsai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3264-3513; OpenAlex author ID A5065379155. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper

Papers 1

Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer. Last author DOI 10.1186/s13578-023-01090-8 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yu-Ching Fan · 1 shared paper, 2023 · strength 0.17
- Paper Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer. DOI 10.1186/s13578-023-01090-8 ↗
Jian-Da Lin · 1 shared paper, 2023 · strength 0.17
- Paper Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer. DOI 10.1186/s13578-023-01090-8 ↗
Florian Bürtin · 1 shared paper, 2023 · strength 0.17
- Paper Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer. DOI 10.1186/s13578-023-01090-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.